PTS Diagnostics Releases Updated A1C Home Monitoring System, Lowers Average Cost Per Test

PTS Diagnostics Releases Updated A1C Home Monitoring System, Lowers Average Cost Per Test

A1CNow® Self Check now comes with approximately one year’s worth of tests

INDIANAPOLIS (Oct. 24, 2018) – PTS Diagnostics, a U.S.–based manufacturer of point-of-caretesting devices, today announced that they are updating their at-home A1CNow Self Check system by doubling the number of A1C tests per package.

Moving from a two-count to a four-count system aligns with the American Diabetes Association’s recommendation of quarterly HbA1c testing in patients whose therapy has changed or who are not meeting glycemic goals.

“Accurate and affordable solutions at the point of care are essential for the management of diabetes and associated comorbidities,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “We’re a leader within the point-of-care industry and are proud to help to reduce the cost of in-home testing while adhering to the recommendations of valued industry associations.”

The increased number of tests may provide greater autonomy for people with diabetes while ensuring compliance with individualized treatment programs. This solution provides the patient with a method to inform the healthcare provider of their glycemic control without the need for frequent office visits.

The A1CNow Self Check is a home measurement system for HbA1c, the two to three-month average of one’s blood glucose. It is trusted throughout the United States’ medical community, provides results in five minutes, has more than a 12 month shelf-life at room temperature and comes with a monitor, test cartridges, fingerstick lancets, and blood collectors.

In addition to home usage, PTS Diagnostics envisions that providers will discover a niche for the updated product within the value-based healthcare system.

“The A1CNow Self Check can be used in conjunction with our PTS Connect® information management solutions to routinely monitor patients,” said Steve Riendeau, Chief Commercial Officer. Increased accessibility will help support new CMS initiatives related to remote patient monitoring and increase overall patient satisfaction.”

The four-count A1CNow Self Check is currently available online through Test Medical Symptoms At Home and in the professional setting through Cardinal Health, Fisher Scientific, Hanson Medical Systems, Henry Schein, and McKesson in the United States. The four-count is available in the European Union and will be rolled out to select countries and additional U.S. distributors in the coming months. Interested parties are encouraged to contact their local distributor, reach out to PTS Diagnostics via phone at 877-870-5610, or email PTS customer service at for more information.

About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From our headquarters in the United States of America, we design, manufacture, and market our products to more than 140 countries around the globe. For more information, visit

Press Contact:
Ryan Simpson, Senior Marketing Associate